Search Within

David Scheinberg

  1. "Lymphoma"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (6)
  3. Conference Paper (1)
Groups
  1. Adult Leukemia (18)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  3. Center for Hematologic Malignancies (18)
  4. Department of Medicine (18)
  5. GSK Faculty (18)
  6. Hematologic Malignancies Research (18)

More Groups

People
  1. Andrew Zelenetz (7)
  2. Anas Younes (5)
  3. Elisa De Stanchina (4)
  4. Mark Weiss (4)
  5. Peter Maslak (4)
  6. Ariela Noy (3)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2017 (2)
  4. 2016 (1)
  5. 2009 (2)
  6. 2006 (1)

More Years

Publications
  1. Blood (7)
  2. Journal of Clinical Oncology (4)
  3. Antibody, Immunoconjugates, and Radiopharmaceuticals (1)
  4. Cancer Discovery (1)
  5. Clinical Cancer Research (1)
  6. JCI Insight (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (4)
  3. American Association for Cancer Research (3)
  4. Amer Soc Clinical Investigation Inc (1)
  5. Impact Journals (1)
  6. Mary Ann Liebert, Inc. (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vaccination with CD20 peptides induces a biologically active, specific immune response in mice
    Journal Article

    Roberts, W. K.; Livingston, P. O.; Agus, D. B.; Pinilla-Ibarz, J.; Zelenetz, A.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • Vaccination with CD20 peptide conjugates induces a biologically active, specific immune response in mice
    Meeting Abstract

    Roberts, W. K.; Agus, D.; Pinilla-Ibarz, J.; Zelenetz, A.; Livingston, P. O.; Scheinberg, D. A.
    Blood (2000)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Journal Article

    Weiss, M. A.; Glenn, M.; Maslak, P.; Rahman, Z.; Noy, A.; Zelenetz, A.; Scheinberg, D. A.; Golde, D. W.
    Leukemia (2000)

    Fulltext@MSK | Save
  • Expression of GM2 and GD2 in B cell lymphomas: Targets for immune attack
    Meeting Abstract

    Zhang, S.; Filippa, D. A.; Zhang, H. S.; Zelenetz, A.; Scheinberg, D.; Livingston, P.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
    Journal Article

    Czuczman, M. S.; Straus, D. J.; Divgi, C. R.; Graham, M.; Garin-Chesa, P.; Finn, R.; Myers, J.; Old, L. J.; Larson, S. M.; Scheinberg, D. A.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • (131)Iodine-labeled monoclonal antibody therapy of acute myelogenous leukemia and B cell lymphoma
    Conference Paper

    Czuczman, M. S.; Divgi, C. R.; Straus, D. J.; Lovett, D. R.; Garin-Chesa, P.; Yeh, S.; Feirt, N.; Graham, M.; Leibel, S.; Gee, T. S.; more...
    Mary Ann Liebert, Inc. (1991)

    Fulltext@MSK | Save
  • A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: Effects of tumor burden and antigen expression
    Journal Article

    Scheinberg, D. A.; Straus, D. J.; Yeh, S. D.; Divgi, C.; Garin-Chesa, P.; Graham, M.; Pentlow, K.; Coit, D.; Oettgen, H. F.; Old, L. J.
    Journal of Clinical Oncology (1990)

    Fulltext@MSK | Save